IBS(SH:603183)2024-04-29 07:37Financial Performance - The company's operating revenue for Q1 2024 was ¥176,458,274.01, representing a year-on-year increase of 7.49%[4] - The net profit attributable to shareholders decreased by 35.80% to ¥3,402,587.46 compared to the same period last year[4] - The net profit for Q1 2024 was CNY 9,124,686.52, slightly up from CNY 9,037,551.76 in Q1 2023, indicating a growth of 1%[16] - The company reported a profit before tax of CNY 11,193,687.35 for Q1 2024, compared to CNY 10,515,591.60 in Q1 2023, representing an increase of 6.4%[16] Cash Flow - The net cash flow from operating activities was negative at ¥26,301,759.70[4] - In Q1 2024, the net cash flow from operating activities was -26,301,759.70, an improvement from -69,433,135.39 in Q1 2023[19] - Cash inflow from operating activities totaled 244,628,484.51, compared to 193,978,834.44 in the same period last year, representing an increase of approximately 26%[18] - Cash outflow from operating activities increased to 270,930,244.21 from 263,411,969.83, reflecting a rise of about 3%[18] - The company reported a total cash inflow from operating activities of 244.63 million, while cash outflow was 270.93 million, leading to a negative cash flow from operations[18] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥2,018,752,613.76, down 5.43% from the end of the previous year[5] - The total assets as of Q1 2024 amounted to CNY 2,018,752,613.76, a decrease from CNY 2,134,688,361.32 in the previous period[13] - Total liabilities for Q1 2024 were CNY 369,351,046.84, down from CNY 494,480,619.97 in Q1 2023, showing a reduction of 25.4%[13] - The company’s equity attributable to shareholders was CNY 1,582,117,589.39, slightly up from CNY 1,578,645,862.88 in the previous year[13] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 24,085[9] - The top shareholder, Wu Xiaoxiang, holds 37,055,723 shares, accounting for 7.40% of the total shares[10] Costs and Expenses - The company experienced an increase in costs, particularly in wages and salaries, contributing to the decline in net profit[7] - Total operating costs for Q1 2024 were CNY 179,395,989.54, up from CNY 162,329,399.69 in Q1 2023, reflecting a rise of 10.5%[14] - Research and development expenses for Q1 2024 were CNY 18,462,973.38, compared to CNY 18,878,161.36 in Q1 2023, indicating a decrease of 2.2%[14] Cash and Investments - The cash and cash equivalents decreased from ¥279,383,691.95 at the end of 2023 to ¥211,225,911.78 by March 31, 2024[11] - The ending cash and cash equivalents balance was 199,057,847.67, up from 180,318,871.93 year-over-year[19] - The net cash flow from investing activities was -37,849,325.17, worsening from -11,325,282.69 in Q1 2023[19] - Cash outflow for investing activities rose significantly to 42,149,725.17 from 11,325,282.69, indicating a substantial increase in investment expenditures[19] - The company plans to continue focusing on investment in fixed assets and intangible assets, with cash outflow for these activities reaching 22,129,725.17 in Q1 2024[19] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[17]